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Abstract
Introduction: Hypocalcemia is common in critically ill patients. However, its clinical course during the early days of
admission and the role of calcium supplementation remain uncertain, and the assessment of calcium status is
inconsistent. We aimed to establish the course of hypocalcemia during the early days of critical illness in relation to
mortality and to assess the impact of calcium supplementation on calcium normalization and mortality.
Methods: Data were collected on 1,038 admissions to the critical care units of a tertiary care hospital. One gram of
calcium gluconate was administered intravenously once daily to patients with adjusted calcium (AdjCa) <2.2
mmol/L. Demographic and outcome data were compared in normocalcemic (ionized calcium, iCa, 1.1-1.3 mmol/L)
and mildly and severely hypocalcemic patients (iCa 0.9-1.1 mmol/L and <0.9 mmol/L, respectively). The change in
iCa concentrations was monitored during the first four days of admission and comparisons between groups were
made using Repeated Measures ANOVA. Comparisons of normalization and outcome were made between
hypocalcemic patients who did and did not receive calcium replacement according to the local protocol. The
suitability of AdjCa to predict low iCa was determined by analyzing sensitivity, specificity and receiver operating
characteristic (ROC) curves. Multivariate logistic regression was performed to determine associations of other
electrolyte derangements with hypocalcemia.
Results: 55.2% of patients were hypocalcemic on admission; 6.2% severely so. Severely hypocalcemic patients
required critical care for longer (P = 0.001) compared to normocalcemic or mildly hypocalcemic patients, but there
was no difference in mortality between groups (P = 0.48). iCa levels normalized within four days in most, with no
difference in normalization between those who died and survived (P = 0.35). Severely hypocalcemic patients who
failed to normalize their iCa by day 4 had double the mortality (38% vs. 19%, P = 0.15). Neither iCa normalization
nor survival were superior in hypocalcemic patients receiving supplementation on admission. AdjCa <2.2 mmol/L
had a sensitivity of 78.2% and specificity of 63.3% for predicting iCa <1.1 mmol/L. Low magnesium, sodium and
albumin were independently associated with hypocalcemia on admission.
Conclusions: Hypocalcemia usually normalizes within the first four days after admission to ICU and failure to
normalize in severely hypocalcemic patients may be associated with increased mortality. Calcium replacement
appears not to improve normalization or mortality. AdjCa is not a good surrogate of iCa in an ICU setting.
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Introduction
Hypocalcemia is a common derangement in both medical
and surgical patients requiring intensive care. The
reported prevalence varies significantly between studies
due to differences in the population studied and the cutoff
values used, with published figures ranging from 15% to
88% [1,2].
The etiology of hypocalcemia in critical illness is multi-
factorial [3,4]. Abnormalities of parathyroid hormone
secretion and action as well as vitamin D deficiency, medi-
cation side effects, transfusion of citrated blood and the
effect of circulating catecholamines are likely to contribute
[1,4-7]. Septic patients are at particular risk of hypocalce-
mia and this has been linked to both the bacteremic state
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and the effect of inflammatory mediators on parathyroid
hormone secretion and function [4,8,9].
A number of studies have reported that hypocalcemia
is associated with poor outcome in different populations
including medical, surgical and trauma patients on both
adult and pediatric intensive care units [2,10-15]. How-
ever, results from recent large studies suggest that it is
only severe hypocalcemia (ionized calcium <0.8 mmol/L
or 0.9 mmol/L) that is independently associated with
mortality [16-18].
It has been advocated that calcium should be replaced
in order to prevent life-threatening complications such as
laryngospasm, tetany, seizures and cardiac abnormalities
[19]. However, studies using experimental models of sep-
sis have shown calcium supplementation to provide
either no benefit or even to increase mortality [20,21].
There is no evidence on the impact of calcium supple-
mentation on outcome in critically ill patients. A recent
systematic review failed to identify any studies that eval-
uated the associations of parenteral calcium supplemen-
tation in intensive care patients and outcomes such as
length of stay and mortality [20]. In addition, neither
the clinical course of hypocalcemia nor the relationship
of normalization to outcome has been established.
Hence it remains controversial whether or not calcium
replacement should be routinely given to critically ill
patients and a more complete understanding of both the
course of hypocalcemia in relation to outcome and the
effect of supplementation is needed.
The assessment of calcium status on the intensive care
unit (ICU) is also inconsistent. Approximately 50% of
total circulating calcium is ionized, which is the biologi-
cally active form. Of the remainder, around 40% is
bound to plasma proteins, particularly albumin, and a
further 10% to anions such as phosphate, sulphate and
citrate [22]. As measurements of total calcium are tradi-
tionally more accessible than those of ionized calcium,
formulas are used to correct the total calcium concen-
tration for variations in albumin concentration in order
to reflect ionized calcium concentrations. However, sev-
eral factors can alter the proportion of total calcium
that is ionized and studies have shown that adjusted cal-
cium formulae do not provide a reliable substitute for
ionized calcium in various groups of critically ill patients
[23-25]. Despite this, adjusted calcium continues to be
used in many ICUs to guide clinical practice.
Other biochemical abnormalities are also common in
critically ill patients, with derangements of sodium,
potassium, magnesium, phosphate, lactate and albumin
frequently seen [26]. Magnesium and phosphate concen-
trations are known to affect calcium homeostasis, how-
ever there has been little study of the interaction of
these abnormalities in the context of hypocalcemia and
greater understanding could improve the therapeutic
approach to hypocalcemic patients[3].
We retrospectively reviewed data from 1,038 admis-
sions to an ICU in which calcium supplementation is
routinely given, in this case guided by the patients’
adjusted calcium level. The primary objectives were to
establish the clinical course of hypocalcemia early in
admission and the relationship of this to outcome, and
to assess the impact of calcium supplementation on nor-
malization of calcium concentration and outcome. In
addition, we determined the suitability of using adjusted
calcium levels in place of ionized calcium to guide clini-
cal practice and examined the association of various bio-
chemical derangements with hypocalcemia.
Materials and methods
This was a single-center, retrospective, observational
study. The population is derived from patients prospec-
tively recruited to a non-interventional study assessing a
biomarker of infection in a full cross-section of intensive
care patients. Patients admitted to the ICU, the postopera-
tive critical care unit or the high dependency unit at Royal
Liverpool University Hospital between January 2008 and
January 2012 were eligible for inclusion. Ethical approval
was obtained from the Bolton Research Ethics Committee
(study 07/H1009/64) and consent was obtained from all
participants. Patients were excluded if valid consent could
not be obtained, if they were discharged, died or put on
the care of the dying pathway within the first 48 h or if
they were admitted after elective surgery.
Admission details, demographic information and the
Acute Physiology and Chronic Health Evaluation
(APACHE) II score were collected and patients followed
up to determine 28-day mortality. A senior clinician
assessed the patient records to determine sepsis status on
a daily basis retrospectively according to the 1992 ACCP/
SCCM consensus guidelines [27]. All blood tests were car-
ried out as part of routine clinical practice and consisted
of daily serum chemistry and 4-hourly blood gas analysis
unless otherwise dictated by clinical need. Results were
retrieved electronically from the hospital laboratory
records and information was held on a study database.
Admission serum biochemistry and blood gas results
(defined as the first available results within 24 h of the
recorded admission date) were extracted from the data-
base alongside the serum biochemistry and blood gas
results at 6 am (+/- 2 hours) for the 3 days following
admission. Missing results were traced by searching
patient records electronically, or manually if necessary.
Ionized calcium (iCa), pH and lactate results were
obtained from blood gas analysis on whole arterial blood
collected in heparinized syringes. Measurements were car-
ried out by trained staff on a RapidLab 1265 blood gas
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analyzer (Siemens Healthcare Diagnostics, Inc.) based on
the ICU. iCa was not adjusted for pH. Sodium and potas-
sium were measured using ion-selective electrodes using
the Roche/Hitachi cobas 8000 ISE analyzer module in the
central hospital laboratory. Total calcium, magnesium,
phosphate and albumin measurements were carried out
with dye-forming reactions detected photometrically using
the Roche/Hitachi cobas c701 analyzer module in the cen-
tral hospital laboratory. Adjusted calcium (AdjCa) is calcu-
lated in this hospital by a locally defined equation based
on the relationship between albumin and total calcium
concentrations [28]: AdjCa (mmol/L) = Total Calcium
(mmol/L) + 0.133(44.1-Albumin (g/L)). Other published
formulas for the adjustment of calcium were also used to
calculate AdjCa values for each patient. The reference
range for AdjCa was 2.2 to 2.6 mmol/L and for iCa it was
1.1 to 1.3 mmol/L.
The protocol for calcium supplementation is outlined in
Figure 1. One gram of calcium gluconate was administered
to all patients with AdjCa <2.2 mmol/L as 10 mL 10% Cal-
cium Gluconate, diluted in 20 mL of normal saline, given
intravenously over 30 min. This was carried out once daily
based on the morning biochemistry analysis for as long as
the AdjCa remained <2.2 mmol/L.
All statistical analysis was performed using SPSS ver-
sion 20 for Windows (IBM). Patients hypercalcemic on
admission were excluded from analyses. Continuous data
were assessed for normality visually by plotting histo-
grams. For normally distributed data the mean (standard
deviation) and parametric tests were used and for non-
normally distributed data the median (interquartile range
(IQR)) and non-parametric tests were used. Categorical
data, quoted as n(%), were assessed using cross-tabula-
tion and the chi squared test for independence. A P value
< 0.05 was taken to be statistically significant. Bonferroni
correction was performed where multiple analyses were
carried out within dependent hypotheses.
The mean 6 am iCa concentration on each day post
admission was calculated to create a time profile of iCa
over the first 4 days of admission. Repeated measures
ANOVA was carried out to assess the effect of time post
admission on iCa concentration and the influence of
between group factors on the time effect. The Greenhouse-
Geisser adjustment was used to generate F and P values.
The diagnostic sensitivity, specificity, positive predic-
tive value (PPV) and negative predictive value (NPV)
value of using AdjCa <2.2 mmol/L (derived from the
laboratory and from other published equations) in pre-
dicting iCa <1.1 mmol/L was assessed. The discrimina-
tive power of AdjCa for predicting iCa was evaluated by
producing receiver operator characteristic (ROC) curves
and by calculating the area under the curve (AUC).
The association between other biochemical derange-
ments and hypocalcemia was assessed by multivariate
logistic regression using iCa <1.1 mmol/L as a binary out-
come. Relevant biochemical factors (sodium, potassium,
phosphate, magnesium, lactate and albumin) and potential
confounding demographic predictors (age, sex, APACHE
II score, sepsis status) with P < 0.25 from the univariate
analysis were included in multivariate logistic regression
model to assess the association with hypocalcemia. Bio-
chemical factors, age and APACHE II score were entered
into the model as continuous linear predictors and sex
and sepsis status as categorical predictors.
Results
Data from 1,038 admissions were available for inclusion
in the study. Demographic information is displayed in
Table 1. The median age on admission was 61 years (IQR
48-73), 56.8% of patients were men and the median
APACHE II score was 18 (IQR 13-23). An iCa measure-
ment within 24 h of admission was available for 976
(94%) patients. The mean admission iCa was 1.08 mmol/
L (SD 0.11) and 539 (55.2%) patients were classified as
hypocalcemic (iCa <1.1 mmol/L). Further subclassifica-
tion revealed that 60 (6.1%) patients were severely hypo-
calcemic on admission (iCa <0.9 mmol/L), 479 (49.1%)
were mildly hypocalcemic (0.9-1.09 mmol/L) and 420
(43%) were normocalcemic (1.1-1.3 mmol/L). Seventeen
(1.7%) were hypercalcemic (>1.3 mmol/L) and excluded
Figure 1 Flow chart outlining calcium supplementation protocol
followed on units in which the study was carried out..
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from further analysis. There was no significant difference
in mortality between severely hypocalcemic, mildly hypo-
calcemic and normocalcemic patients (23.3% vs. 19.4% vs.
17.4%, respectively (P = 0.477, chi squared test)). There
was, however, a significant difference in length of stay
(14 vs. 9 vs. 8 days; P = 0.001, Kruskal Wallis test).
Change in ionized calcium level over the first 4 days of
admission
To study how ionized calcium concentration changed over
the first 4 days of admission to ICU, the mean of iCa mea-
surements taken on admission and at 06:00 on days 2, 3,
and four were plotted (Figure 2). By the fourth day of their
stay the mean level for patients with severe and mild hypo-
calcemia on admission had normalized (Figure 2A). Of
those severely hypocalcemic on admission, 24 (53%) had an
iCa <1.1 mmol/L on day 4, compared to 121 (35.2%) of
those mildly hypocalcemic and 64 (21.9%) of those normo-
calcemic (P = 0.001, Table 2). There was no difference in
the influence of time on iCa concentration over the first 4
days between those who survived and those who died. Also,
no difference was found between patients with and without
sepsis, as confirmed by repeated measures ANOVA (P =
0.35 and P = 0.1 respectively; Figure 2B and 2C).
Subsequently, the mortality rates of patients who did
and did not normalize their iCa level by day 4 were com-
pared by cross-tabulating results and using the chi-
squared test for independence (Table 2). Overall, 30% of
patients were hypocalcemic on day 4 and there was no dif-
ference in mortality between these patients and those who
were not (P = 0.76). Over half of patients with severe
hypocalcemia on admission failed to normalize iCa over
the first 4 days, whereas 65% of mildly hypocalcemic
patients had normal iCa on day 4. There was an increased
mortality in those patients who were severely hypocalcemic
on admission and had iCa <1.1 mmol/L on day 4 (37.5% vs.
19%), although this was not statistically significant (P =
0.15), possibly due to the small sample size (n = 24 with
day 4 iCa <1.1 mmol/L and n = 21 with day 4 iCa >1.1
mmol/L). In patients with mild hypocalcemia on admission
there was no difference in mortality between those who did
and did not normalize their iCa level (n = 223 and n = 121
respectively; P = 0.71). Furthermore, the proportion of
patients with normal iCa on day 4 was similar in survivors
and non-survivors (63.1 vs. 61.4%; P = 0.76) and in those
with and without sepsis (61.9% vs. 64.4%; P = 0.63).
Impact of calcium supplementation on normalization of
hypocalcemia and survival
Adjusted calcium (AdjCa) was available on admission for
1,031 (99.3%) patients and the median level was 2.17
mmol/L (IQR 2.07-2.25). 602 (58%) were classified as hypo-
calcemic (<2.2 mmol/L) and met criteria for calcium sup-
plementation, 416 (40.3%) were normocalcemic and 13
(1.3%) were hypercalcemic (>2.6 mmol/L). Of patients with
hypocalcemia as defined by the gold standard (iCa <1.1
mmol/L), 419 (78%) had AdjCa <2.2 mmol/L, and thus
received calcium supplementation in accordance with the
local protocol. The overall survival in this group was no
different to those with AdjCa <2.2 mmol/L not meeting
criteria for supplementation (80.2% and 81.6%, respectively,
P = 0.12). In addition, there was no difference in the med-
ian increase in iCa levels over the first 24 h between hypo-
calcemic patients receiving supplementation and those
who did not (0.06 mmol/L (0.02-0.12) and 0.06 mmol/L
(0.01-0.11), respectively, P = 0.35). The results were similar
when looking across the full 4 days (0.11 mmol/L (0.04-
0.18) and 0.1 mmol/L (0.03-0.16), respectively; P = 0.34).
Table 1 Baseline variables for all patients and for those normocalcemic and hypocalcemic.





Age (years) 61 (48-73) 63 (47-73) 61 (49.5-72) 0.83
Male sex 590 (56.8) 246 (58.6) 298 (55.3) 0.31
APACHE II score 18 (13-23) 18 (13-23) 19 (14-23) 0.18
Septic during first 3 days 531 (51.2) 199 (47.4) 308 (57.2) 0.002
Alive at 28 days 848 (81.7) 347 (82.6) 432 (80.1) 0.33
Length of stay (days) 8 (4-16) 8 (4-15.5) 9 (4-19) 0.04
pH 7.38 (7.3-7.44) 7.38 (7.31-7.44) 7.37 (7.3-7.44) 0.54
Sodium 138 (134-141) 138 (135-144) 137 (133-141) 0.015
Potassium 4.2 (3.8-4.6) 4.2 (3.8-4.6) 4.2 (3.8-4.7) 0.6
Phosphate 1.19 (0.91-1.53) 1.14 (0.91-1.44) 1.27 (0.91-1.61) 0.003
Magnesium 0.78 (0.66-0.89) 0.8 (0.69-0.89) 0.75 (0.64-0.89) 0.002
Lactate 1.5 (1-2.5) 1.4 (1-2.3) 1.7 (1.1-2.8) <0.001
Albumin 24 (18-30) 26 (20-33) 21 (21-26) <0.001
Values represent total (%) for categorical variables and median (interquartile range) for continuous variables. Mann-Whitney U test used for continuous variables,
chi-squared test for categorical.
APACHE2, Acute Physiology and Chronic Health Evaluation II score.
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Figure 2 Time course of mean ionized calcium concentrations over the first 4 days of admission. The mean ionized calcium
concentrations for various population subgroups at admission and at 06:00 for the following 3 days are plotted. Repeated measures ANOVA was
carried out for linear changes in iCa over the period. F and P values are based on the Greenhouse-Geisser adjustment. (A) Changes in mean
ionized calcium concentrations for normocalcemic, mildly hypocalcemic and severely hypoclacemic patients. Time effect F = 273.6; P < 0.001,
effect of calcium status on time effect F = 102.7; P < 0.001. (B) Comparison of changes in mean iCa concentration for patients that survived and
those that died. Time effect F = 82.4; P < 0.001, effect of survival group on time effect F = 1.06; P = 0.35. (C) Comparison of changes in iCa
between those who did and did not have sepsis within 3 days of admission as determined by a senior consultant using APPC/SCCM consensus
guidelines. Time effect F = 99.2; P < 0.001, effect of sepsis status on time effect F = 2.22; P = 0.058. (D) Comparison of changes in iCa levels in
patients with ionised hypocalcemia on admission who also had adjusted calcium <2.2 mmol/L and therefore received calcium supplementation
and those who did not. Time effect F = 135.1; P < 0.001, effect of adjCa status on time effect F = 1.86; P = 0.15.
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Repeated measures ANOVA showed that the effect of time
on iCa level was not significantly different between those
who did and did not receive supplementation on admission
(P = 0.15, Figure 2D).
Adjusted calcium for guiding therapeutic practice on the
ICU
The local AdjCa cutoff of 2.2 mmol/L had a sensitivity of
78.2% and specificity of 63.3% for detecting iCa <1.1
mmol/L in this population (Table 3). Other formulas for
adjusting total calcium levels were also assessed but none
could give both a high sensitivity and specificity at the
cutoff values used (Table 3). The largest area under the
curve (0.81; 95% CI 0.78-0.83) came from the formula
AdjCa=Total Ca+0.00839(32.9-Alb) (Figure 3). Due to
the potential importance of severe hypocalcemia, the
ability of AdjCa to predict this was also assessed. AdjCa
<2 mmol/L, derived from the locally validated formula,
had a sensitivity of 60%, a specificity of 89% and a PPV of
just 27% for detecting iCa <0.9 mmol/L. The sensitivity
and specificity of AdjCa <2.2 mmol/L for predicting iCa
<1.1 mmol/L did not improve in patients with normal
pH (74.9% and 67.7%, respectively) or normal serum
phosphate (80.3% and 58.8%, respectively).
Association of biochemical derangements and
hypocalcemia
Univariate analysis indicated that the proportion of
patients who developed sepsis within 3 days of admission
differed significantly between hypocalcemic and normocal-
cemic patients (57.2% vs. 47.4%; P = 0.002; Table 1). There
were also significant differences between the median
admission sodium, phosphate, magnesium, lactate and
albumin between the groups (Table 1). On multivariate
logistic regression analysis lower admission sodium (odds
ratio 0.96 (95% CI 0.94-0.99)), magnesium (0.37 (95% CI
0.17-0.81)), and albumin (0.93 (95% CI 0.91-0.94)) were
significantly associated with low iCa, as was raised lactate
(1.11 (95% CI1.03-1.2). Low admission phosphate showed
a trend, but was not significantly associated with low iCa
(P = 0.052; Table 4).
Discussion
In this large retrospective, observational study hypocalce-
mia was a very common abnormality in patients upon
admission to intensive care. The prevalence of 55% was
slightly lower than recently reported values, which have
ranged to beyond 80%, probably reflecting higher cut off
values for hypocalcemia [2,16,17]. We chose an ionized
Table 2 Prevalence of hypocalcaemia on day 4 and mortality in different patient subgroups.
Subgroup Day 4 iCa (mmol/L) n (%) P valuea Mortality P valueb
All patients <1.1 210 (30) 46 (21.9)
>1.1 489 (70) - 102 (20.9) 0.76
Admission iCa <0.9 mmol/L <1.1 24 (53.3) 9 (37.5)
>1.1 21 (46.7) 4 (19) 0.15*
Admisson iCa 0.9-1.09 mmol/L <1.1 121 (35.2) 25 (20.7)
>1.1 223 (64.8) 50 (22.4) 0.71*
Admission iCa 1.1-1.3 mmol/L <1.1 64 (21.9) 12 (18.8)
>1.1 228 (78.1) 0.001 45 (19.7) 0.86*
Hypocalcemia & sepsis <1.1 98 (38.1) 24 (24.5)
>1.1 159 (61.9) 34 (21.4) 0.56**
Hypocalcemia & no sepsis <1.1 47 (35.6) 10 (21.3)
>1.1 85 (64.4) 0.63 20 (23.5) 0.77**
Admission iCa <1.1 mmol/L:
Survivors
<1.1 111 (36.9) 0
>1.1 190 (63.1) 0
Admission iCa <1.1 mmol/L:
Non-survivors
<1.1 34 (38.6) 100
>1.1 54 (61.4) 0.76 100 -
Adm iCa <1.1 & AdjCa <2.2 mmol/L (given supplementation) <1.1 121 (39.7) 29 (24.0)
>1.1 184 (60.3) 42 (22.8) 0.82**
Adm iCa <1.1 & AdjCa >2.2 mmol/L (not given supplementation) <1.1 24 (28.9) 5 (20.8)
>1.1 59 (71.1) 0.073 12 (20.3) 0.96**
Mortality is reported as n (%). All P values are derived from the chi-squared test for independence between groups.
aDifference in % patients with iCa >1.1 mmol/L by day 4 between subgroups.
bDifference in mortality by day 4 iCa status within each subgroup.
Bonferroni correction was performed where multiple subgroup analyses were carried out; *P < 0.017, **P < 0.025 required for statistically significant result.
AdjCa, Adjusted calcium; iCa, Ionized calcium.
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calcium concentration of 1.1 mmol/L as cutoff, as this is
the lower reference value in our hospital. Other papers
have used values lower than this, highlighting the difficulty
in comparing prevalence figures [15].
In contrast to several previous reports we found no sig-
nificant association between hypocalcemia on admission
and mortality [10-15]. Several authors have described a
significantly higher mortality rate in severely hypocalce-
mic patients in particular and suggested that it is in this
group in which the association is clinically significant
[16-18]. We could not confirm this, despite a trend in
that direction, probably due to the small number of
severely hypocalcemic patients in our study. However, in
our study, patients with low ionized calcium had a longer
stay on the ICU, and this finding was most prominent in
severely hypocalcemic patients. It is uncertain whether
this is a causal relationship as severely hypocalcemic
patients may represent a more severely ill subset of inten-
sive care patients, requiring longer stays. Alternatively,
the diagnoses of severely hypocalcemic patients may dif-
fer from other groups, although assessing this possibility
is beyond the scope of this study.
To our knowledge, this is the first study to describe the
time course of calcium levels over the early days of
admission to intensive care. We found that both mild
and severe hypocalcemia shows sustained improvement
over the first 4 days of admission. There was no differ-
ence in the pattern of change of ionized calcium concen-
trations in survivors and non-survivors. Furthermore, in
patients with mild hypocalcemia on admission, there was
no difference in mortality between those who did and did
not normalize their ionized calcium by day 4 post admis-
sion. However, among patients with severe hypocalcemia
on admission, there was a notable but not statistically sig-
nificant increase in mortality in those who had failed to
normalize their ionized calcium levels by day 4. The fail-
ure to reach statistical significance was most likely due to
the small number of patients who were severely hypocal-
cemic on admission and in whom calcium levels were
available on day 4. It appears that in patients with mild
hypocalcemia on admission, normalization of ionized cal-
cium level does not have an influence on mortality. How-
ever, in patients with severe hypocalcemia, normalization
of calcium concentrations may be less likely to occur and
mortality may be higher in this group, suggesting they
could be targets for intervention.
Table 3 The performance of locally validated and published formulas for adjusted calcium in predicting hypocalcemia.
Formula Sens (%) Spec (%) PPV NPV AUC (95% CI)
Locally Validated AdjCa=Total Ca+0.013(44.1-Alb) 78.2 63.3 72.4 70.2 0.78 (0.75-0.81)
Traditionally quoted [24] AdjCa=Total Ca+0.02(40-Alb) 60.4 69.0 70.6 58.7 0.71 (0.68-0.74)
Slomp et al. [24] AdjCa=Total Ca+0.025(40-Alb) 32.3 78.9 65.4 48.6 0.64 (0.61-0.68)
Slomp et al. [24] AdjCa=Total Ca+0.00839(32.9-Alb) 97.4 16.7 59 83.9 0.81 (0.78-0.83)
Hypocalcemia defined as iCa <1.1 mmol/L, and AdjCa cutoff was 2.2 mmol/L.
AdjCa, adjusted calcium (mmol/L); Alb, Albumin concentration (g/L); AUC, area under the curve; NPV, negative predictive value; PPV, positive predictive value;
Sens, sensitivity; Spec, specificity; Total Ca, Total calcium (mmol/L).
Figure 3 ROC curves for albumin-adjusted calcium in predicting
iCa <1.1. Receiver operating characteristic curves displaying the
performance of albumin-adjusted calcium in predicting hypocalcemia.
Different lines represent different formulae used, locally defined and in
the literature [23]. Hypocalcemia is defined as iCa <1.1 mmol/L.
Table 4 Multivariate logistic regression analysis for
biochemical abnormalities with hypocalcemia.
Explanatory variable OR (95% CI) P value
APACHE II 1.00 (0.98-1.02) 0.72
Sepsis (first 3 days) 1.03 (0.76-1.38) 0.87
Sodium 0.96 (0.94-0.99) 0.002
Phosphate 1.30 (1.00-1.69) 0.052
Magnesium 0.37 (0.17-0.81) 0.013
Lactate 1.11 (1.03-1.20) 0.007
Albumin 0.93 (0.91-0.94) <0.001
Variables entered into model were those with P < 0.25 on univariate analysis.
APACHE II, sodium, phosphate, magnesium, lactate and albumin were
continuous predictors, entered linearly and sepsis a binary predictor. Outcome
was iCa <1.1 mmol/L.
APACHE II, Acute Physiology and Chronic Health Evaluation II score; CI,
Confidence interval; OR, Odds ratio (for ionized calcium <1.1 mmol/L).
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Our study is set apart from others in that many partici-
pants received intravenous calcium supplementation as
part of a standard protocol. This was guided by adjusted
rather than ionized calcium, allowing analysis of whether
this practice affected the normalization of ionized cal-
cium concentration and outcome. We found that the
pattern of change over time and the proportion of hypo-
calcemic patients with a normal ionized calcium concen-
tration by day 4 were not different between those who
did and did not receive calcium supplementation. Our
results suggest that calcium supplementation does not
lead to a greater sustained increase in ionized calcium
than occurs without supplementation. This is in keeping
with previous reports suggesting that calcium supple-
mentation does not increase ionized calcium concentra-
tions in critical illness and that calcium concentrations
cannot be corrected by calcium therapy alone [20,29,30].
However, it needs to be taken into consideration that our
study was retrospective and observational and hence
lacks controlled intervention.
Normally, ionized calcium concentrations are tightly
regulated and hypocalcemia can have profound adverse
clinical effects [19]. Furthermore, intravenous calcium
has an important role in hemodynamic support [31].
Interestingly, however, it has been shown that in sepsis
and during treatment with catecholamines calcium is
shifted into the cells, which may contribute to the hypo-
calcemia seen in the critically ill [7,32,33]. Raised intra-
cellular calcium concentrations have in turn been linked
to the pathophysiology of sepsis [33]. Giving additional
parenteral calcium could therefore cause harm, a con-
cept which is supported by experimental models of sep-
sis in which calcium administration was associated with
higher mortality [20,21]. In keeping with this, it has fre-
quently been suggested that hypocalcemia is a marker of
disease severity, rather than a contributor in itself, indi-
cating therapy is unwarranted [17,22].
Despite this, the role of calcium replacement in hypo-
calcemic patients remains unclear and requires further
study. The results of this investigation are limited as the
study design was retrospective and purely observational,
no controlled intervention was performed and not all
confounders could be eliminated. In particular, some
patients may have received calcium supplementation
prior to admission to intensive care and the route of
nutrition (enteral vs. parenteral) was not included in the
analysis. Finally, although the overall sample size was
large, the rarity of severe hypocalcemia renders the study
underpowered to make conclusions in this subgroup.
As a secondary finding, this study confirmed that a low
adjusted calcium concentration is a relatively poor surro-
gate for identifying critically ill patients with low ionized
calcium concentrations, despite its widespread use for
this purpose. The adjustment of total calcium is based on
a formula incorporating the relationship between total
calcium and albumin, derived from the linear regression
equation and the difference of the patient’s albumin from
the population average [28]. In the present study, a for-
mula developed from results of patients in our hospital
has been used and therefore neither epidemiological fac-
tors nor differences in equipment could account for the
limitations described.
There are a number of plausible physiological explana-
tions for adjusted calcium being a poor predictor for
ionized calcium in critically ill patients. They include
alterations in pH affecting calcium-albumin binding,
deranged serum concentrations of phosphate, which che-
lates calcium, or changes in blood concentrations of citrate
and fatty acids [23,34]. We found that low adjusted cal-
cium remained a poor predictor of low ionized calcium,
even when looking solely at patients without derange-
ments of pH and phosphate concentration. As a result we
propose that, wherever available, measurement of ionized
calcium rather than adjusted calcium should be performed
to define hypocalcemia. Only if ionized claclium cannot be
measured, adjusted calcium should be calculated, with the
formula published by Stomp providing the best area under
the curve [23].
The finding that lower magnesium, sodium and albu-
min were independently associated with ionized hypo-
calcemia, with a strong trend for higher phosphate,
suggests these biochemical derangements should be spe-
cifically considered in the assessment of hypocalcemic
patients. This is unsurprising as magnesium deficiency
in particular is a known cause of hypocalcemia due to
impaired parathyroid hormone secretion and end organ
resistance [3,35].
Conclusions
Hypocalcemia is a common finding in patients admitted to
a general ICU. In this large cohort of patients, levels
tended to normalize over the early days of admission and
this was not associated with outcome. However, patients
severely hypocalcemic on admission whose calcium failed
to rebound to normal trended towards having a higher
mortality and may be a target for intervention. Findings
also indicate that calcium supplementation is not asso-
ciated with calcium normalization or improved outcome,
although this study was observational in nature. A large
randomized controlled trial of calcium supplementation in
critically ill patients with different degrees of hypocalcemia
is required to determine the effectiveness and side effects
of this treatment and its role in clinical practice.
Key messages
• Hypocalcaemia is common in critical illness but
tends to normalize during the early days of admission
to intensive care.
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• In most cases normalization of calcium status is
not associated with improved outcome, however
mortality may be higher in severely hypocalcaemic
patients who remain hypocalcemic on the fourth day
of their admission.
• Calcium supplementation does not improve either
calcium normalization or survival and a large rando-
mized controlled trial is required to assess the effec-
tiveness and side effects of this intervention.
• Albumin-adjusted calcium is a poor predictor of
low ionized calcium in critical illness and should not
be used in this setting.
• Low magnesium, sodium and albumin are indepen-
dently associated with low ionized calcium and this
should be considered in the overall management of
each patient.
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